HAPRULO
Live / Allowed — Fourth extension granted (statement of use) (as of 03 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Nov 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98290658
- Mark type
- Word mark
- Filed
- 29 Nov 2023
- Published for opposition
- 06 Aug 2024
- Attorney of record
- Lisa Greenwald-Swire
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, and brain disorders
Owner
- Neumora Therapeutics, Inc., Watertown, MA, US
- Neumora Therapeutics, Inc., Watertown, MA, US
Prosecution history
- 04 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Aug 2026 — SOU EXTENSION 4 GRANTED
- 03 Aug 2026 — SOU EXTENSION 4 FILED
- 03 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 14 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Feb 2026 — SOU EXTENSION 3 GRANTED
- 04 Feb 2026 — SOU EXTENSION 3 FILED
- 04 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Aug 2025 — SOU EXTENSION 2 GRANTED
- 14 Aug 2025 — SOU EXTENSION 2 FILED
- 14 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Oct 2024 — SOU EXTENSION 1 GRANTED
- 02 Oct 2024 — SOU EXTENSION 1 FILED